Central nervous system tumours in childhood: Their clinical-pathological aspects;Tumores del sistema nervioso central en la infancia: Aspectos clinicopatológicos

Revista de Neurologia

Volumn 38, Issue 6, 2004, Pages 554-564

  Ortega Aznar, Arantxa ^a   Romero Vidal, F J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Children; CNS; CNS tumours; Paediatric tumours

Indexed keywords

AGE DISTRIBUTION; CANCER DIAGNOSIS; CANCER INCIDENCE; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; MENINGIOMA; MOLECULAR GENETICS; NOMENCLATURE; REVIEW; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

EID: 2142717464     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3806.2003417     Document Type: Review

References (70)

1. Kleihues P, Cavenee WK. WHO classification of tumors. Pathology & genetics of tumours of the nervous system. Lyon: IARC Press; 2000.
2. Burger PC, Scheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings. New York: Churchill-Livingstone; 2002.
3. Batra SK, Rasheed BK, Bigner SH, Bigner DD. Biology of disease. Oncogenes and anti-oncogenes in human central nervous system tumors. Lab Invest 1994; 71: 621-37.
4. James CD, Carlbom E, Dumanski JP, Hausen M, Nordenskjold MD, Collins VP, Cavenee W. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988; 48: 5546-51.
5. Louis DN, Cavenee WK. Molecular biology of central nervous system neoplasms. In De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5 ed. Philadelphia: Lippincott-Raven Publishers; 1997. p. 2013-22.
6. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miler DC. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 1993; 3: 229-35.
7. Ohgaki H, Schauble B, Zur H, Von Ammon K, Kleihues P. Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 1995; 427: 113-8.
8. Sidransky D, Mikelsen T, Schwechheimer K, Rosemblum ML, Cavenee WK, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 1992; 355: 846-7.
9. Watanabe K, Sato K, Biemat W, Tachibana O, Von Ammon K, Ogata N, et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 1997; 3: 523-30.
10. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996; 6: 217-24.
11. Claesson W. Platelet-derived growth factor receptor signals. J Biol Chem 1994; 269: 32023-6.
12. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res 1996; 56: 164-71.
13. Louis DN, Holland EC, Cairncross JG. Glioma classification: a molecular reappraisal. Am J Pathol 2001; 159: 779-86.
14. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavanee, WK, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-33.
15. Rickert CH, Probst-Cousin S, Gullota F. Primary intracranial neoplasm of infancy and early childhood. Childs Nerv Syst 1997; 13: 507-13.
16. Pollack IF, Claassen D, Al Shboul Q, Janosky JE, Deutsch M. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 1995; 82: 536-47.
17. Gilles FH, Brown WD, Leviton A, Tavare CJ, Adelman L, Rorke LB, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children brain tumor consortium. Cancer; 2000; 88: 1477-83.
18. Gilles FH, Leviton A, Tavare CJ, Adelman L, Rorke LB, Sobel EL, et al. Definitive classes of childhood supratentorial neuroglial tumors. The childhood brain tumor consortium. Pediatr Dev Pathol 2000; 3: 126-39.
19. Giannini C, Scheithauer BW. Classification and grading of low-grade astrocytic tumors in children. Brain Pathol 1997; 7: 785-98.
20. Burger PC, Scheithauer BW, Lee RR, O'Neill BP. An interdisciplinary approach, to avoid the overtreatment of patients with central nervous system lesions. Cancer 1997; 80: 2040-6.
21. Burger PC, Breiter SN, Fisher PG. Pylociyic and fibrillary astrocytomas of the brain stem -a comparative clinical, radiological, and pathological study. J Neurosurg Exp Neurol 1996; 55: 640.
22. Lee YY, Van Tassel P, Bruner JM, Moser RP, Share JC. Juvenile pilocytic astrocytomas: CT and MR characteristics. AJNR Am J Neuroradiol 1989; 10: 363-70.
23. Cottingham SL, Boesel CP, Yates AJ. Pilocytic astrocytoma in infants: a distinctive histological pattern. J Neurosurg Exp Neurol 1996; 55: 654-8.
24. Pollack IF, Hurtt M, Pang D, Allbright AL. Dissemination of lowgrade intracranial astrocytomas in children. Cancer 1994; 73: 2869-78.
25. Versari P, Talamonti G, D'Aliberti G. Leptomeningeal. dissemination of juvenile pilocytic astrocytoma: case report. Surg Neurol 1994; 41: 318-21.
26. Tomlinson FH, Scheithauer BW, Hayostek CJ, Parisi JE, Meyer FB, Shaw EG, et al. The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinicopathologic and flow cytometric study. J Child Neurol 1994; 9: 301-10.
27. Ushio Y, Arita N, Yoshimine T. Malignant recurrence of childhood cerebellar astrocytoma: case report. Neurosurgery 1987; 21: 251-5.
28. Haapasalo H, Sallinen S, Sallinen P. Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas. Neuropathol Appl Neurobiol 1999; 25: 13442.
29. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. Von Recklinghausen neurofibromatosis. Incidence of optic glioma. Ophtalmology 1984; 91: 929-35.
30. Garner A, Klinworth GK. Tumors of the orbit, optic nerve and lacrimal sac. In: Pathobiology of ocular disease. New York: Marcel Dekker; 1982; p. 741.
31. Dirks PB, Jay V, Becker LE, Drake JM, Humphreys RP, Hoffman HJ, et al. Development of anaplastic changes in low grade astrocytomas of childhood. Neurosurgery 1994; 34: 68-78.
32. Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favourable prognosis, a study of 12 cases. Cancer 1979; 44: 1839-52.
33. Burger PC, Scheithauer BW. Tumors of the central nervous system. Atlas of tumor pathology. Washington DC: AFIP; 1994.
34. Ironside JW, Moss TH, Louis DN, Lowe JS, Weller RO. Diagnostic pathology of nervous system tumours. London: Churchill-Livingstone; 2002.
35. Fernandez López-Lara L, Ortega-Aznar A, Romero-Vidal FJ. Tumores cerebrales. In Romero-Vidal FJ, ed. Neuroimagen clínica. Madrid: Arán; 1999. p. 341-402.
36. Romero-Vidal FJ, Ortega-Aznar A. Hemispheric brain tumors. In Gourtsoyiannis N, Ros PR, eds. Syllabus radiologic-pathologic correlations. European Radiology. Berlin: Springer-Verlag; 2000. p. S33-49.
37. Romero-Vidal FJ, Ortega-Aznar A. Diagnóstico por imagen: TAC/RMN. In Arraez MA, Herruzo I, Acha T, Benavides M, eds. Tumores del sistema nervioso central en el adulto y en la infancia. Enfoque multidisciplinario neurooncológico. Madrid: Nova Sidonia; 2003. p. 113-35.
38. Rosenblum MK. Ependymal tumors: a review of their diagnostic surgical pathology. Pediatr Neurosurg 1998; 28: 160-5.
39. Prayson RA. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol 1999; 3: 11-8.
40. Schiffer D, Cavalla P, Migheli A, Chio A, Giordana MT, Marino S, et al. Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci Lett 1995; 195: 81-4.
41. Schiffer D, Chio A, Cravioto H, Giordana MT, Migheli A, Soffietti R. Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgery 1991; 29: 206-10.
42. Ernestus RI, Schroder R, Stutzer H, Klug N. The clinical and prognostic relevance of grading in intracranial ependymomas. Br J Neurosurg 1997; 11: 421-8.
43. Emestus RI, Schroder R, Stutzer H, Klug N. Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 1996; 12: 522-6.
44. Afra D, Muller W, Slowik, F, Wilcke O, Budka H, Turoczy L. Supratentorial lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir (Wien) 1983; 69: 243-51.
45. Figarella-Branger D, Gambarelli D, Dollo C, Devictor B, Pérez-Castillo AM, Genitori L, et al. Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases. Acta Neuropathol (Berl) 1991; 82: 208-16.
46. Ortega-Aznar A, Romero-Vidal FJ, De la Torre J, Castellví J, Nogués P. Neonatal tumors of the CNS: a report of 9 cases and a review. Clin Neuropathol 2001; 20: 181-9.
47. Pomeroy SL, Tamayo P, Gaassenbeek M. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002; 415: 436-2.
48. Cruz-Sánchez FF, Rossi ML, Hughes JT, Moss TH. Differentiation in embryonal neuroepithelial tumors of the central nervous system. Cancer 1991; 67: 965-76.
49. Mitchell D, Rojiani AM, Richards D. Congenital CNS primitive neuroectodermal tumor: case report and review of the literature. Pediatr Pathol Lab Med 1995; 15: 949-56.
50. Cervoni I, Cantore G. Medulloblastoma in pediatric age: a single-institution review of prognostic factors. Childs Nerv Syst 1995; 11: 80-5.
51. Coffin CM, Braun JT, Wick MR, Dehner LP. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression. Mod Pathol 1990; 3: 164-70.
52. Eberhart CG, Kaufman W, Burger PC. Apoptosis neuronal maturation and neurotropin signalling within medulloblastoma nodules. J Neuropathol Exp Neurol 2001; 60: 462-9.
53. Giangaspero F, Perilongo G, Fondelli MP. Medulloblastoma with extensive nodularity: a variant with favourable prognosis. J Neurosurg 1999; 91: 971-7.
54. Herms J, Neidt I, Luscher B, Sommer A, Sehurmann P, Schroder T, et al. C-myc expression in medulloblastoma and its prognostic value. Int J Cancer 2000; 89: 395-402.
55. Khorsumov A, Golanov A, Ozerov S, Sycheva R. Prognostic value of tumor-associated antigens immunoreactivity and apoptosis in medulloblastomas: an analysis of 73 cases. Brain Tumor Pathol 1999; 16: 3749.
56. Roberts RO, Lynch CF, Jones MP, Hart MN. Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol 1991; 50: 134-44.
57. Giangaspero F, Chieco P, Ceccarelli C, Lisignoli G, Pozzuoli R, Gambacorta M, et al. 'Desmoplastic' versus 'classic' medulloblastoma comparison of DNA content, histopathology and differentiation. Virchows Arch A Pathol Anat 1991; 418: 207-14.
58. Giangaspero F, Rigobello L, Badiali M, Loda M, Andreini L, Basso G, et al. Large-cell medulloblastomas. Am J Surg Pathol 1992; 16: 687-93.
59. Zurawel RH, Allen C, Chiappa S, Cato W, Biegel J, Cogen P, et al. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 2000; 27: 44-51.
60. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI 1 in atypical teratoid rhabdoid tumors. Cancer Res 1999; 59: 74-9.
61. Gessi M, Giangaspero F, Pietsch T. Atypical teratoid/rhabdoid tumors and choroid plexus tumors: when genetics surprise pathology. Brain Pathol 2003; 13: 409-14.
62. Perry A, Dehner LP. Meningeal tumors of childhood and infancy. An update and literature review. Brain Pathol 2003; 13: 386-408.
63. Baumgartner JE, Sorenson JM. Meningioma in the pediatric population. J Neurooncol 1996; 29: 223-8.
64. Perry A, Giannini C, Raghavan R, Scheithauer BW, Banerjee R, Margraf L, et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 2001; 60: 994-1003.
65. Sandberg DI, Edgar MA, Resch L, Rutka JT, Becker LE, Souweidane MM. MIB-1 staining index of pediatric meningiomas. Neurosurgery 2001; 48: 590-7.
66. Bailey W, Freidenberg GR, James HE, Hesselink JR, Jones KL. Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging. Prenat Diagn 1990; 10: 623-9.
67. Pierre-Kahn A, Brauner R, Renier D, Sainte-Rose C, Gangemi MA, Rappaport R, et al. Treatment of craniopharyngiomas in children. Retrospective analysis of 50 cases. Arch Fr Pediatr 1988; 45: 163-7.
68. Hoffman HJ, Hendrick EB, Humphreys RP, Buncic JR, Amstrong DL, Jenkin RD. Management of craniopharyngioma in children. J Neurosurg 1977; 47: 218-27.
69. Yasargil MG, Curcic M, Kis M. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 1990; 73: 3-11.
70. Hoffman HJ, De Silva M, Humpreys RP, Drake JM, Smith ML, Blazer SL. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992; 76: 47-52.